Publications – KalVista Pharmaceuticals | KalVista Pharmaceuticals

Patients & Caregivers
- About HAE
Healthcare Professionals
Clinical Trials
Presentations & Publications
Investors & News

About
Science
Pipeline
Careers
- Careers
- Job Openings
Contact

Bringing new developments to Light

Presentations & Publications

We are committed to rigorous science and innovative drug development, and we are excited to share our ongoing progress.

Explore Our
Virtual Medical Booth

Reset all ×
Oral Factor XIIa inhibitor ×
2024 ×

Apply Reset

Topic

Sebetralstat (KVD900) in HAE clinical program (0)
HAE attack journey data (0)
HAE burden of treatment data (0)
Oral Factor XIIa inhibitor (1)
Kallikrein-Kinin System science (0)

Forum

Medical Meeting (1)
Publication (0)

Year

2023 (0)
2022 (0)
2024 (1)

Apply Reset

Showing 1 out of 1

A sensitive and specific assay to characterize plasma kallikrein activity in plasma from hereditary angioedema patients

Lee D, Ghannam A, Murugesan N, Vincent D, Mogg A, Smith M, Hampton S, Feener E
EAACI 2024

About

Management team

Board of Directors

Science

Pipeline

Oral Factor XIIa Inhibitor

Careers

Contact

KalVista Terms of Use Privacy Policy

© 2024 KalVista Pharmaceuticals. All Rights Reserved.